Martha Notaras
CIK: 0001803071
Martha Notaras's purchase track record
Martha Notaras has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/7/2025 | PLMR | $12K | -4.2% | +5.1% | +7.2% |
| 11/8/2021 | PLMR | $150K | -42.4% | -46.1% | -15.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PLMR | ▲ Buy | Option Exercise | 1,722 | $100K | 6/2/2026 | View on chart |
| PLMR | ▲ Buy | Grant | 1,304 | $0 | 5/21/2026 | View on chart |
| PLMR | ▲ Buy | Open Market | 100 | $12K | 8/7/2025 | View on chart |
| PLMR | ▲ Buy | Grant | 715 | $0 | 5/22/2025 | View on chart |
| PLMR | ▲ Buy | Grant | 1,224 | $0 | 5/23/2024 | View on chart |
| PLMR | ▲ Buy | Grant | 1,639 | $0 | 5/25/2023 | View on chart |
| PLMR | ▲ Buy | Grant | 963 | $0 | 5/26/2022 | View on chart |
| PLMR | ▲ Buy | Open Market | 1,587 | $150K | 11/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Palomar Holdings Gets AM Best Rating Affirmation and JPMorgan Target Cut
AM Best affirmed the credit ratings for Palomar Holdings and its member companies, reinforcing the firm's financial stability. Concurrently, JPMorgan maintained its Overweight rating but lowered its price target to $156. These updates provide a neutral backdrop for the stock, which is currently trading near its 52-week high.
Palomar Holdings Gets AM Best Rating Affirmation and JPMorgan Target Cut. AM Best affirmed the credit ratings for Palomar Holdings and its member companies, reinforcing the firm's financial stability. Concurrently, JPMorgan maintained its Overweight rating but lowered its price target to $156. These updates provide a neutral backdrop for the stock, which is currently trading near its 52-week high.